Literature DB >> 7573918

Low gastric intramucosal pH: incidence and significance in intensive care patients.

T J Trinder1, G G Lavery, J P Fee, K G Lowry.   

Abstract

Monitoring of gastric intramucosal pH (pHi) is advocated in critical illness to detect tissue acidosis due to regional hypoperfusion. However, the number of patients who may benefit from such monitoring remains unclear and the relationship between low pHi and outcome requires further definition. Sixty consecutive patients with Acute Physiology and Chronic Health Evaluation (APACHE II) scores < 30 were studied throughout ICU stay to investigate the incidence of low pHi (< 7.32 for > or = 1 hour), its relationship to outcome, and temporally associated clinical events. pHi was measured 2 to 6 hours post-ICU admission and 8-hourly thereafter. Forty-four patients (73%) exhibited low pHi. Fourteen patients died in ICU with 13 deaths occurring in the low pHi group (P = 0.05). Length of ICU stay was greater in the low pHi group (P = 0.02). The development of low pHi was temporally associated with maximal sepsis score, weaning from assisted ventilation and commencement of enteral feeding.

Entities:  

Mesh:

Year:  1995        PMID: 7573918     DOI: 10.1177/0310057X9502300308

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  3 in total

1.  Tonometry to estimate intestinal perfusion in newborn piglets.

Authors:  M E Campbell; J E Van Aerde; P Y Cheung; D C Mayes
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

2.  Gastric tonometry in septic shock.

Authors:  M Hatherill; S M Tibby; R Evans; I A Murdoch
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

3.  Gastric PgCO2 and Pg-aCO2 gap are related to D-lactate and not to L-lactate levels in patients with septic shock.

Authors:  Martijn Poeze; Barbara C J Solberg; Jan Willem M Greve; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-10-08       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.